FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024259013> ?p ?o ?g. }

• W2024259013 endingPage "222" @default.
• W2024259013 startingPage "222" @default.
• W2024259013 abstract "This study was performed to evaluate the treatment results, prognostic factors and complication rates in patients with locally advanced cancer of uterine cervix after radiotherapy with high-dose rate (HDR) brachytherapy.One hundred and twenty patients with a locally advanced (stages IIB approximately IVA according to FIGO classification) carcinoma of the uterine cervix were treated with radiotherapy at the Department of Radiation Oncology, Samsung Medical Center between September 1994 and December 2001. The median age of the patients was 61 years (range 29 to 81). Sixty-one, 56 and 3 patients had FIGO stage IIB, III, and IV diseases, respectively. All patients were given external beam radiotherapy over the whole pelvis (median 50.4 Gy) and HDR intracavitary brachytherapy, with a median of 4 Gy per fraction, to point A. Twenty-one patients received chemotherapy, of which 13 and 21 received neoadjuvant chemotherapy and concurrent chemotherapy, respectively, during the first and fourth weeks of external beam radiotherapy. The chemotherapy was not randomly assigned and the median follow-up time was 28.5 months (range: 6 approximately 100 months).The three- and 5-year overall survival (OS) and disease-free survival (DFS) rates were 64.4 and 57.0%, and 63.7 and 60.2%, respectively. The 5-year OS and DFS rates of the patients at stages IIB, III and IV were 60.2, 57.9 and 33.3%, and 57.4, 65.4 and 33.3%, respectively. Univariate analysis indicated that the FIGO stage, overall treatment time (OTT) and treatment response were significant variables for the OS (p=0.035, p=0.0649 and p=0.0009) and of the DFS (p=0.0009, p=0.0359 and p=0.0363). Multivariate analysis showed that the treatment response was the only significant variable for the OS (p=0.0018) and OTT for the DFS (p=0.0360). The overall incidence of late complications in the rectum and bladder were 11.7 and 6.7%, respectively. In addition, insufficiency fractures were observed in 7 patients (5.8%).The results of this study suggest that radical radiotherapy with HDR brachytherapy was appropriate for the treatment of locally advanced uterine cervix cancer. Also, the response after treatment and OTT are significant prognostic factors." @default.
• W2024259013 created "2016-06-24" @default.
• W2024259013 creator A5001928028 @default.
• W2024259013 creator A5013851036 @default.
• W2024259013 creator A5016919074 @default.
• W2024259013 creator A5018732774 @default.
• W2024259013 creator A5025322881 @default.
• W2024259013 creator A5033422411 @default.
• W2024259013 creator A5045026176 @default.
• W2024259013 creator A5045830586 @default.
• W2024259013 creator A5064346645 @default.
• W2024259013 creator A5064707258 @default.
• W2024259013 creator A5073802304 @default.
• W2024259013 creator A5079382353 @default.
• W2024259013 creator A5080692176 @default.
• W2024259013 creator A5090552664 @default.
• W2024259013 creator A5090899532 @default.
• W2024259013 date "2004-01-01" @default.
• W2024259013 modified "2023-09-26" @default.
• W2024259013 title "Radical Radiotherapy for Locally Advanced Cancer of Uterine Cervix" @default.
• W2024259013 cites W1972856800 @default.
• W2024259013 cites W1993717128 @default.
• W2024259013 cites W1997109941 @default.
• W2024259013 cites W2014254368 @default.
• W2024259013 cites W2014501764 @default.
• W2024259013 cites W2019388282 @default.
• W2024259013 cites W2057989265 @default.
• W2024259013 cites W2075543032 @default.
• W2024259013 cites W2105536678 @default.
• W2024259013 cites W2128492489 @default.
• W2024259013 cites W2137197268 @default.
• W2024259013 cites W2153639787 @default.
• W2024259013 cites W2168560581 @default.
• W2024259013 cites W2419639294 @default.
• W2024259013 cites W2916405371 @default.
• W2024259013 cites W3023840541 @default.
• W2024259013 cites W4251656587 @default.
• W2024259013 cites W4361808197 @default.
• W2024259013 doi "https://doi.org/10.4143/crt.2004.36.4.222" @default.
• W2024259013 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2843887" @default.
• W2024259013 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20368838" @default.
• W2024259013 hasPublicationYear "2004" @default.
• W2024259013 type Work @default.
• W2024259013 sameAs 2024259013 @default.
• W2024259013 citedByCount "8" @default.
• W2024259013 countsByYear W20242590132016 @default.
• W2024259013 countsByYear W20242590132018 @default.
• W2024259013 countsByYear W20242590132019 @default.
• W2024259013 countsByYear W20242590132022 @default.
• W2024259013 countsByYear W20242590132023 @default.
• W2024259013 crossrefType "journal-article" @default.
• W2024259013 hasAuthorship W2024259013A5001928028 @default.
• W2024259013 hasAuthorship W2024259013A5013851036 @default.
• W2024259013 hasAuthorship W2024259013A5016919074 @default.
• W2024259013 hasAuthorship W2024259013A5018732774 @default.
• W2024259013 hasAuthorship W2024259013A5025322881 @default.
• W2024259013 hasAuthorship W2024259013A5033422411 @default.
• W2024259013 hasAuthorship W2024259013A5045026176 @default.
• W2024259013 hasAuthorship W2024259013A5045830586 @default.
• W2024259013 hasAuthorship W2024259013A5064346645 @default.
• W2024259013 hasAuthorship W2024259013A5064707258 @default.
• W2024259013 hasAuthorship W2024259013A5073802304 @default.
• W2024259013 hasAuthorship W2024259013A5079382353 @default.
• W2024259013 hasAuthorship W2024259013A5080692176 @default.
• W2024259013 hasAuthorship W2024259013A5090552664 @default.
• W2024259013 hasAuthorship W2024259013A5090899532 @default.
• W2024259013 hasBestOaLocation W20242590131 @default.
• W2024259013 hasConcept C121608353 @default.
• W2024259013 hasConcept C126322002 @default.
• W2024259013 hasConcept C141071460 @default.
• W2024259013 hasConcept C144301174 @default.
• W2024259013 hasConcept C146357865 @default.
• W2024259013 hasConcept C151730666 @default.
• W2024259013 hasConcept C2775908122 @default.
• W2024259013 hasConcept C2776694085 @default.
• W2024259013 hasConcept C2777416452 @default.
• W2024259013 hasConcept C2777740455 @default.
• W2024259013 hasConcept C2778220009 @default.
• W2024259013 hasConcept C38180746 @default.
• W2024259013 hasConcept C509974204 @default.
• W2024259013 hasConcept C71924100 @default.
• W2024259013 hasConcept C86803240 @default.
• W2024259013 hasConceptScore W2024259013C121608353 @default.
• W2024259013 hasConceptScore W2024259013C126322002 @default.
• W2024259013 hasConceptScore W2024259013C141071460 @default.
• W2024259013 hasConceptScore W2024259013C144301174 @default.
• W2024259013 hasConceptScore W2024259013C146357865 @default.
• W2024259013 hasConceptScore W2024259013C151730666 @default.
• W2024259013 hasConceptScore W2024259013C2775908122 @default.
• W2024259013 hasConceptScore W2024259013C2776694085 @default.
• W2024259013 hasConceptScore W2024259013C2777416452 @default.
• W2024259013 hasConceptScore W2024259013C2777740455 @default.
• W2024259013 hasConceptScore W2024259013C2778220009 @default.
• W2024259013 hasConceptScore W2024259013C38180746 @default.
• W2024259013 hasConceptScore W2024259013C509974204 @default.
• W2024259013 hasConceptScore W2024259013C71924100 @default.
• W2024259013 hasConceptScore W2024259013C86803240 @default.
• W2024259013 hasIssue "4" @default.

• next